Chinook Therapeutics Inc Cvr (ADRO)
R&D to Revenue
388.49%
Fiscal year · Period ending:
ADRO R&D to Revenue
Latest reported388.49%period ending
Latest reported388.49%period ending
ADRO FY R&D/Revenue (1290.70% → 388.49%)
Latest values, visible window
High-resolution chart · PNG
ADRO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 388.4865% | |
| 502.6579% | |
| 518.4872% | |
| 173.0787% | |
| 80.3642% | |
| 175.6143% | |
| 1,290.7005% |